Lindsay Ackerman, MD, FAAD

Lindsay Ackerman, MD, FAAD, shares practical insights on managing vitiligo with topical ruxolitinib, addressing patient expectations, safety, and evolving research gaps.

Lindsay Ackerman, MD, explains the importance of transparency when prescribing medications with boxed warnings.

The Phoenix-based dermatologist encourages innovative and patient-tailored strategies to optimize pigment restoration.

Lindsay Ackerman, MD, outlines how ruxolitinib topical has transformed the clinical approach to vitiligo.